Re-Engineered Discharge for Diabetes Care Transitions
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Massachusetts, Worcester
About this trial
The goal of this project is to test a novel bedside SDOH screening intervention coupled with post-discharge navigation for hospitalized patients with a diabetes diagnosis to reduce unmet social needs, compared to usual care.
Eligibility criteria
Qualifiers
adult aged 18 years or older
diagnosed with type 2 diabetes
hospitalized at Univ of Massachusetts-affiliated hospital
endorsed at least 1 unmet social need via screening survey
Disqualifiers
pregnancy
discharge to short or long-term nursing facility or hospital
medical contraindication
cognitive impairment
Trial design
Treatments tested in this trial
- REDDCAT2 Post-Discharge Navigation
- Treatment as Usual (TAU)
Treatment groups
412 Participants
are divided into 2 treatment groupsLocations
1UMASS Memorial Healthcare System01665, WorcesterMassachusetts, United States
Sponsors and collaborators
University of Massachusetts, Worcester
Lead sponsor
National Institute of Nursing Research (NINR)
Collaborator
Regents of the University of Michigan
Collaborator
Source ClinicalTrials.gov